A Leading provider of regulatory solutions, data intelligence databases, trends & insights to make better informed decisions
Sciinov Insights foresee customer success through their products and services along with other biopharma players.
What sets us apart?
Most granular market segmentation in the industry
In-depth profiles of key market players providing a competitive landscape
High level analysis of major market segments and identification of opportunities
Each insight derives from the depth and breadth of the drug development cycle, includes technology, drug phase, molecule structure, route of administration, disease analysis, multiple entities such as originator, licensor, licensee, technology partner, CRO, CDMO/CMO, clinical trial location, investigator, pivotal trial, patents, future events, drug price and reimbursement.
Products
Data is sourced from company pipelines, annual reports, regulatory websites, clinical trial registries, scientific and investor conferences, press releases, and SEC filings. It covers pipeline and approved drugs, planned, ongoing, completed, as well as terminated/suspended/withdrawn trials.
We keep you informed, profound and favorable decisions to encompass the advantages of upcoming trends, progressions, estimations, and opportunities through our precise understanding of the market.
View More
We keep you informed, profound and favorable decisions to encompass the advantages of upcoming trends, progressions, estimations, and opportunities through our precise understanding of the market.
View More
The reports are enhanced using industry benchmark methodologies to provide data, analysis, and insights across well-established countries.
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Benefits includes: Hundreds of indications covered, Integrated data product, Rare disease visibility, Disease-area expertise, and Ease of access
View More
Company Intelligence Tool provides similar companies by headquarters, disease area, nature of molecule, pipeline/approved stages and business type. Provides ready-to-use templates by company with basic details, financials, key people, drug sales and performance matrix.
Clinical trial planner provides subjects/site/investigators availability by drug indication, phase and nature of molecule, and enrollment size.
View More
Sciinov's news letter covers advanced therapies, companies financing, licensing deals, merger & acquisitions, drug development, regulatory updates, key people hiring and new companies.
These will act as business leads for service providers and inverstor companies.
View More
Great Sciinov Group Ideas
News and Announcements
Great Sciinov Group Ideas
Featured Reports
Vaccines Market: Global Forecast to 2026
Market by Technology (Recombinant, Toxoid, Conjugate, RNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Influenza, DTP, HPV, MMR, COVID-19), Route of Administration (IM, SC, Oral), End user (Pediatric, Adult)
Biosimilars: Global Forecast to 2026
Market by Product (Monoclonal antibodies (infliximab, rituximab, trastuzumab), Insulin, Interferon, Etanercept, Glucagon, Calcitonin), Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease), Region
Europe General Anesthesia Drugs: Global Forecast to 2026
Market by Route of Administration (Intravenous and Inhalational), End User (Hospitals, Ambulatory Surgery Centers)
Have a business Query? Let's Talk.
Email : info@sciinovgroup.com or Call : USA: +1 732 526 1166
India: +91 7997224449
Get The Latest Updates
Signup For Newsletter
